News

APEL client and server source code. Contribute to apel/apel development by creating an account on GitHub.
Innovation-focused leader with a proven track record of driving outsized growth and profitability to lead the company's next chapter FREMONT, Calif., July 1, 2025 /PRNewswire/ -- Q’Apel Medical ...
Q’Apel said factors other than the device’s tip likely contributed to the reported adverse events, adding that the problems are a known risk of all aspiration catheters. Q’Apel is one of several ...
The ATF has not yet released a statement regarding the lawsuit. Elyse Apel is a reporter for The Center Square covering Colorado and Michigan. A graduate of Hillsdale College, Elyse’s writing has been ...
A group of some 12 Dutch men and women set up their own border checks on the N366 between Ter Apel and Rütenbrock in Germany on Saturday evening, wearing high-visibility clothing and flagging down ...
There, Apel Mahmud proved his status as a freedom fighter. “If Apel Mahmud had only been involved in singing songs and inspiring others, he would have been considered an associate freedom fighter.
While President Donald Trump declared earlier this year that “DEI… is dead,” June’s Pride Month antics will provide the testing grounds for whether the diversity gods still have a pulse ...
Q'Apel Medical has removed the Hippo - Cheetah product from the market permanently. "We are pleased with the resolution of this litigation,” said Tony Chou, M.D., founder and chief executive officer ...
Route 92 Medical announced that it settled the patent litigation filed against Q'Apel Medical over delivery catheter intellectual property.
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel ...
Q’Apel Medical announced that the FDA classified a voluntary recall of its 072 Aspiration System as Class I, the most serious kind.
PASADENA, Calif., April 15, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that, effective May 13, 2025, Arrowhead’s Chief Financial Officer, Ken Myszkowski, will retire ...